Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapy

Leuk Lymphoma. 2012 Oct;53(10):2063-5. doi: 10.3109/10428194.2012.670232. Epub 2012 Apr 19.

Authors

Roberto Crocchiolo, Joseph Ciccolini, Jean El-Cheikh, Sabine Fürst, Luca Castagna, Angela Granata, Claire Oudin, Samia Harbi, Raynier Devillier, Stevan Legall, David Ternant, Gilles Paintaud, Bruno Lacarelle, Didier Blaise

PMID: 22372847
DOI: 10.3109/10428194.2012.670232

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Bilirubin / blood
Epstein-Barr Virus Infections / drug therapy*
Epstein-Barr Virus Infections / etiology
Female
Hematopoietic Stem Cell Transplantation / adverse effects
Herpesvirus 4, Human / genetics
Humans
Immunologic Factors / therapeutic use*
Meningoencephalitis / drug therapy*
Meningoencephalitis / etiology
Middle Aged
Rituximab
Transplantation, Homologous
Treatment Outcome
Viral Load

Substances

Antibodies, Monoclonal, Murine-Derived
Immunologic Factors
Rituximab
Bilirubin